Effectiveness of GenoType MTBDR sl in excluding TB drug resistance in a clinical trial (2021)
Attributed to:
Paediatric and adolescent infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5588/ijtld.21.0212
PubMed Identifier: 34615581
Publication URI: http://europepmc.org/abstract/MED/34615581
Type: Journal Article/Review
Parent Publication: The International Journal of Tuberculosis and Lung Disease
Issue: 10
ISSN: 1027-3719